The role of Toll-like receptor 4 in high-glucose-induced inflammatory and fibrosis markers in human peritoneal mesothelial cells (original) (raw)

Abstract

Purpose

High glucose stimulates peritoneal inflammation and extracellular matrix accumulation in human peritoneal mesothelial cells (HPMCs). However, the roles of Toll-like receptor 4 (TLR4) and TLR2 in high-glucose-induced inflammation and fibrosis in peritoneal dialysis (PD) remain unclear. This study aimed to evaluate the effect of high glucose on TLR2 and TLR4 expression in HPMCs and to assess their impact on peritoneal inflammatory and fibrosis markers.

Methods

Using cultured HPMCs, TLRs expression by high-glucose (50 mM) stimulation was assessed by quantitative real-time PCR. The association of reactive oxygen species (ROS) in high-glucose-induced TLR2 and TLR4 expression was measured by 2′,7′-dichlorodihydrofluorescein diacetate staining with or without ROS inhibitor. In addition, the role of TLR2 and TLR4 on high-glucose-induced inflammatory and fibrosis markers including chemoattractant protein-1 (MCP-1), NF-κB, alpha-smooth muscle actin (α-SMA), transforming growth factor-β (TGF-ß), and fibronectin was evaluated after inhibition of TLR2 and TLR4 by small-interfering RNA (siRNA) or anti-TLR4/TLR2 antibodies, respectively.

Results

High glucose induced TLR1, TLR2, and TLR4 mRNAs expressions. High-glucose-induced TLR4 and TLR2 mRNAs were associated partly with the generation of ROS. Inhibition of TLR4 attenuated the high-glucose-induced expression of MCP-1 mRNA and protein, MyD88 mRNA, nuclear NF-κB p65 protein, TGF-β, fibronectin, and α-SMA mRNA and protein. However, inhibition of TLR2 did not change the expression of MCP-1 mRNA and protein.

Conclusions

High glucose induces inflammatory and fibrosis markers in HPMCs partly through the TLR4/MyD88/NF-κB signaling pathway rather than TLR2. Therefore, TLR4 might be a therapeutic target for ameliorating peritoneal inflammation and fibrosis in PD.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lai KN, Tang SC, Leung JC (2007) Mediators of inflammation and fibrosis. Perit Dial Int 27(Suppl 2):S65–S71
    PubMed Google Scholar
  2. Sakamoto N, Sugimura K, Kawashima H, Tsuchida K, Takemoto Y, Naganuma T, Tatsumi S, Nakatani T (2005) Influence of glucose and inflammatory cytokines on TGF-β1 and CTGF mRNA expressions in human peritoneal mesothelial cells. Int J Mol Med 15:907–911
    CAS PubMed Google Scholar
  3. Schilte MN, Celie JW, Wee PM, Beelen RH, van den Born J (2009) Factors contributing to peritoneal tissue remodeling in peritoneal dialysis. Perit Dial Int 29:605–617
    CAS PubMed Google Scholar
  4. Yung S, Chan TM (2009) Intrinsic cells: mesothelial cells—central players in regulating inflammation and resolution. Perit Dial Int 29(Suppl 2):S21–S27
    CAS PubMed Google Scholar
  5. Ha HY, Yu MR, Lee HB (2001) High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 59:463–470
    Article CAS PubMed Google Scholar
  6. Mudaliar H, Pollock C, Komala MG, Chadban S, Wu H, Panchapakesan U (2013) The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. Am J Physiol Renal Physiol 305:F142–F154. doi:10.1152/ajprenal.00398.2012
    Article Google Scholar
  7. Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I (2008) High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 57:3090–3098. doi:10.2337/db08-0564
    Article CAS PubMed PubMed Central Google Scholar
  8. Michelsen KS, Doherty TM, Shah PK, Arditi M (2004) TLR signaling: an emerging bridge from innate immunity to atherogenesis. J Immunol 173:5901–5907
    Article CAS PubMed Google Scholar
  9. Colmont CS, Raby AC, Dioszeghy V, Lebouder E, Foster TL, Jones SA, Labéta MO, Fielding CA, Topley N (2011) Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of toll-like receptors. Nephrol Dial Transpl 26:4079–4090. doi:10.1093/ndt/gfr217
    Article CAS Google Scholar
  10. Ha H, Lee HB (2000) Effect of high glucose on peritoneal mesothelial cell biology. Perit Dial Int 20(Supple 2):S15–S18
    PubMed Google Scholar
  11. Kato S, Yuzawa Y, Tsuboi N, Maruyama S, Morita Y, Matsuguchi T, Matsuo S (2004) Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4. J Am Soc Nephrol 15:1289–1299
    CAS PubMed Google Scholar
  12. Curtiss LK, Black AS, Bonnet DJ, Tobias PS (2012) Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists. J Lipid Res 53(10):2126–2132. doi:10.1194/jlr.M028431
    Article CAS PubMed PubMed Central Google Scholar
  13. Tsan MF, Gao B (2007) Pathogen-associated molecular pattern contamination as putative endogenous ligands of toll-like receptors. J Endotoxin Res 13:6–14
    Article CAS PubMed Google Scholar
  14. Pulskens WP, Rampanelli E, Teske GJ, Butter LM, Claessen N, Luirink IK, van der Poll T, Florquin S, Leemans JC (2010) TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury. J Am Soc Nephrol 21:1299–1308. doi:10.1681/ASN.2009070722
    Article CAS PubMed PubMed Central Google Scholar
  15. Lin M, Yiu WH, Wu HJ, Chan LY, Leung JC, Au WS, Chan KW, Lai KN, Tang SC (2012) Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol 23:86–102
    Article CAS PubMed Google Scholar
  16. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13:1324–1332
    Article CAS PubMed Google Scholar
  17. Devaraj S, Tobias P, Jialal I (2011) Knockout of toll-like receptor-4 attenuates the pro-inflammtory state of diabetes. Cytokine 55:441–445. doi:10.1016/j.cyto.2011.03.023
    Article CAS PubMed Google Scholar
  18. Jialal I, Major AM, Devaraj S (2014) Global toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy. J Diabetes Complicat 28:755–761
    Article PubMed Google Scholar
  19. Mudaliar H, Pollock C, Ma J, Wu H, Chadban S, Panchapakesan U (2014) The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose. PLoS ONE 9(10):e108844. doi:10.1371/journal.pone.0108844
    Article PubMed PubMed Central Google Scholar
  20. Hritz I, Mandrekar P, Velayudham A, Catalano D, Dolganiuc A, Kodys K, Kurt-Jones E, Szabo G (2008) The critical role of toll-like receptor (TLR4) in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 48:1224–1231
    Article CAS PubMed Google Scholar
  21. Lee IT, Shih RH, Lin CC, Chen JT, Yang CM (2012) Role of TLR4/NADPH oxidase/ROS-activated p38 MAPK in VCAM-1 expression induced by lipopolysaccharide in human renal mesangial cells. Cell Commun Signal 10:33. doi:10.1186/1478-811X-10-33
    Article CAS PubMed PubMed Central Google Scholar
  22. Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E (2004) Involvement of reactive oxygen species in toll-like receptor 4-dependent activation of NF-kappa B. J Immunol 172:2522–2529
    Article CAS PubMed Google Scholar

Download references

Acknowledgments

This study was supported by grants from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2012R1A1A3007350), the Korean Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A111345), and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (HI15C0001).

Author information

Authors and Affiliations

  1. Division of Nephrology, Department of Internal Medicine, Kyungpook National University Hospital, Kyungpook National University School of Medicine, 130 Dongduk Ro, Jung-gu, Daegu, 700-721, South Korea
    Soon-Youn Choi, Hye-Myung Ryu, Ji-Young Choi, Jang-Hee Cho, Chan-Duck Kim, Yong-Lim Kim & Sun-Hee Park
  2. BK21 Plus Biomedical Convergence Program, Department of Biomedical Science, Kyungpook National University, Daegu, South Korea
    Soon-Youn Choi & Yong-Lim Kim

Authors

  1. Soon-Youn Choi
    You can also search for this author inPubMed Google Scholar
  2. Hye-Myung Ryu
    You can also search for this author inPubMed Google Scholar
  3. Ji-Young Choi
    You can also search for this author inPubMed Google Scholar
  4. Jang-Hee Cho
    You can also search for this author inPubMed Google Scholar
  5. Chan-Duck Kim
    You can also search for this author inPubMed Google Scholar
  6. Yong-Lim Kim
    You can also search for this author inPubMed Google Scholar
  7. Sun-Hee Park
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toSun-Hee Park.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standard

All procedures performed in studies involving human patients were in accordance with the guidelines of the 2008 version of the Declaration of Helsinki and approved by Institutional Review Board of Kyungpook National University Hospital (IRB 2016-02-034-001).

Informed consent was obtained from all individual participants who agreed to collect residual tissue during the elective surgery.

Rights and permissions

About this article

Cite this article

Choi, SY., Ryu, HM., Choi, JY. et al. The role of Toll-like receptor 4 in high-glucose-induced inflammatory and fibrosis markers in human peritoneal mesothelial cells.Int Urol Nephrol 49, 171–181 (2017). https://doi.org/10.1007/s11255-016-1430-9

Download citation

Keywords